Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Author: Benzinga Insights | February 23, 2023 09:06am

Gainers

  • TransMedics Group (NASDAQ:TMDX) stock moved upwards by 16.4% to $75.1 during Thursday's pre-market session. The market value of their outstanding shares is at $2.3 billion. The company's, Q4 earnings came out yesterday.
  • Adamis Pharmaceuticals (NASDAQ:ADMP) stock rose 15.23% to $0.32. The market value of their outstanding shares is at $47.9 million.
  • Jounce Therapeutics (NASDAQ:JNCE) stock moved upwards by 15.1% to $1.14. The company's market cap stands at $58.9 million.
  • Celyad Oncology (NASDAQ:CYAD) stock moved upwards by 14.91% to $1.31. The market value of their outstanding shares is at $29.5 million.
  • Calliditas Therapeutics (NASDAQ:CALT) shares moved upwards by 13.72% to $20.47. The market value of their outstanding shares is at $609.8 million. As per the press release, Q4 earnings came out today.
  • Lantheus Holdings (NASDAQ:LNTH) stock rose 12.44% to $65.5. The market value of their outstanding shares is at $4.5 billion. As per the press release, Q4 earnings came out today.

Losers

  • Lucira Health (NASDAQ:LHDX) stock fell 38.0% to $0.14 during Thursday's pre-market session. The company's market cap stands at $5.7 million.
  • Infinity Pharmaceuticals (NASDAQ:INFI) stock declined by 29.1% to $0.39. The market value of their outstanding shares is at $34.8 million.
  • Aprea Therapeutics (NASDAQ:APRE) stock declined by 14.43% to $5.4. The company's market cap stands at $14.3 million.
  • Assertio Holdings (NASDAQ:ASRT) shares fell 8.41% to $4.9. The company's market cap stands at $236.6 million.
  • Immix Biopharma (NASDAQ:IMMX) shares decreased by 8.19% to $2.13. The market value of their outstanding shares is at $29.6 million.
  • Processa Pharma (NASDAQ:PCSA) shares declined by 8.13% to $0.66. The company's market cap stands at $16.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ADMP APRE ASRT CALT CYAD IMMX INFI JNCE LHDX LNTH PCSA TMDX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist